The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases

Overview

The objective of this study is to look at the effects of distractive auditory stimuli (DAS) on reducing dyspnea intensity and related anxiety and increasing exercise tolerance. Investigators hope that compared to a no-music control condition, that under a music condition participants with COPD will (a) demonstrate increased self-paced walk distance and enjoyment; (b) have less dyspnea intensity, (c) experience less dyspnea anxiety; (d) have less fatigue and state anxiety; and (e) higher maximum heart rate. The upbeat music with a tempo of 90 – 100 bpm (an average-to-moderate walking tempo) is expected to have distractive and performance enhancing effects in order to increase tolerance to dyspnea and exercise. The long-term goal of this study is to increase physical activity in adults with COPD and RLD by promoting dyspnea and fatigue management through use of distractive auditory stimuli in the form of music.

Full Title of Study: “The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Disease”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Supportive Care
    • Masking: Double (Participant, Investigator)
  • Study Primary Completion Date: November 14, 2018

Detailed Description

This randomized clinical trial will use a cross-over design. The research will include two within-subject factors, music versus no music and time. Each subject will be randomized a single time to receive either music first then no music, or alternatively, no music first then music during two walk tests.

Interventions

  • Procedure: Distractive Auditory Stimuli
    • Participants will self-select 1 music piece from a list of choices to keep the rhythm and tempo consistent throughout the 6MWT. The instructions to participants for selecting the music will be standardized. TThe music volume will be standardized to be “moderately loud” as rated by participants for the music condition. Participants will not be specifically instructed to synchronize their walking movements with the music tempo. The music is based on a cognitive therapy (distraction) strategy conceptual framework. Music will be played during the 6MWT (in-task) only.
  • Procedure: No Distractive Auditory Stimuli
    • Participants will wear headphones with no music playing

Arms, Groups and Cohorts

  • Experimental: music first then no music
  • Experimental: no music first then music

Clinical Trial Outcome Measures

Primary Measures

  • Dyspnea Intensity (DI)
    • Time Frame: 60 Minutes
    • Borg Breathlessness Scale. The Borg dyspnea scale is a single-item rating scale, ranging between 0, “nothing at all”, and 10, “very, very severe (maximal)”. Patients will be asked to rate their level of dyspnea during the walk test using the 10-point Borg scale after the 6MWT.64 Validity of the Borg scale for measuring dyspnea intensity has been shown.65

Participating in This Clinical Trial

Inclusion Criteria

  • English speaking – aged 40 years or older, with physician-diagnosed COPD – a flow volume loop with a FEV1/FVC of < 0.70 in the past 12 months – medically cleared to participate in NYULMC's pulmonary rehabilitation program. Exclusion Criteria:

  • Inability to exercise due to musculoskeletalor neurological dysfunction – Inability to walk independently (unaided) – deafness or severe hearing impairment requiring hearing aids – mMRC score = 0 ("I only get breathlessness with strenuous exercise").

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • NYU Langone Health
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Anna Maria Norweg, Principal Investigator, New York University Medical School

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.